Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and mFOLFOX6 in KRAS Wild-type Unresectable Liver Metastases of Colorectal Cancer
NCT01322178Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Dec 2010
- Primary completion
- Jun 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in colorectal cancer (CRC), liver metastases, sponsored by Fudan University. Status: unknown.
02
Drugs
KL-140
03
Conditions
colorectal cancer (CRC)liver metastases
Beyond the preview
Go deeper on NCT01322178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01322178.